March 2011
Elevance Welcomes John Harvey as Vice President of Manufacturing
Elevance is pleased to welcome John Harvey, a 25-year veteran of the chemical industry, as vice president of manufacturing. John will be responsible for building Elevance’s manufacturing capability to support the start-up and operations of Elevance’s biorefineries.
John’s extensive knowledge of our customer’s needs and technology will allow for growth with our manufacturing partners. John has an impressive record of building motivated teams that have established safety records, controlled costs and improved profits in more than seven different production facilities.
John was previously site director for the Chocolate Bayou Olefins & Polypropylene manufacturing facility at INEOS Olefins & Polymers, an operation with more than $4 billion in assets. He also worked for Amoco and BP in various engineering and manufacturing capacities, including building and optimizing the production of engineering polymers, refinery products, foams, fibers and other intermediate and specialty chemicals.
Welcome to Elevance, John!
Elevance Named Top VC Deal of Q4 2010
Elevance’s $100 million investment by Naxos Capital Partners, Total Energy Ventures International, TPG Biotech and TPG Growth, was named one of the largest US venture capital (VC) investment deals in Q4 2010 in the Industry Products and Services segment by Ernst & Young, LLP.
According to Ernst & Young, “VC investment in cleantech companies increased by 8% to $3.98 billion in 2010. Cleantech in Q4 2010 reached $979 million with 72 financing rounds. VC investment in cleantech in Q4 2010 reached $979 million with 72 financing rounds.”
This proves that activity in the cleantech industries is increasing, and Elevance is proud to be part of this emerging industry.
Our strong relationships with our investors and partners have helped Elevance grow significantly in the last three years as we continue development of high performance specialty chemicals and products.
With the support of these resources and technology, we have been able to move both our business and the bio-based industry forward in the past and look forward to significant additional advancements this year.
Social Media